High-Throughput Screening Services Market Outlook Highlights The Next Major Growth Opportunities
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
High-Throughput Screening Services Market Value Expansion And Long-Term Growth Outlook
The high-throughput screening services market has seen rapid growth in its size over recent years. Projections indicate it will expand from $23.02 billion in 2025 to $25.54 billion by 2026, reflecting a compound annual growth rate (CAGR) of 11.0%. The expansion observed in prior periods can be attributed to the broadening of pharmaceutical R&D initiatives, the increasing adoption of combinatorial chemistry libraries, the integration of automated liquid handling systems, a rising need for swift target identification, and the accessibility of extensive compound libraries.
The high-throughput screening services market is projected for significant expansion in the coming years, reaching $39.06 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.2%. This growth during the forecast period is attributable to several factors, including heightened investments in precision drug discovery, an increased emphasis on biologics and intricate targets, the expansion of personalized medicine research, the expanding application of AI-assisted screening workflows, and the growing trend of outsourcing screening services to Contract Research Organizations (CROs). Key trends anticipated in this period encompass the increased deployment of automated robotic screening platforms, a surging demand for ultra-high-throughput screening services, wider acceptance of cell-based and label-free assays, the broadening of AI-driven data analysis within drug discovery, and a sharpened focus on expediting hit-to-lead identification.
Download A Free Sample Report For Comprehensive Market Insights:
#High-Throughput Screening Services Market Growth Drivers And Industry Catalysts
The increasing occurrence of chronic and complex diseases is anticipated to boost the high-throughput screening services market. These conditions are characterized as long-term illnesses involving multiple biological pathways, requiring extended management rather than quick fixes. Their rising prevalence stems significantly from aging global populations, lifestyle-related risk factors, and enhanced disease detection, collectively escalating the burden on healthcare systems and stimulating the need for advanced therapeutic solutions. High-throughput screening (HTS) services facilitate research into chronic and complex diseases by enabling rapid and simultaneous testing of numerous compounds against biological targets. This capability accelerates initial drug discovery, refines target identification, and supports the development of more effective treatments for multifactorial, long-duration conditions. For instance, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, approximately 76.4% of adults in the United States, representing more than 194 million people—reported having at least one chronic condition in 2023, while 51.4% (around 131 million people) reported multiple chronic conditions. Thus, the expanding presence of chronic and complex diseases is fueling the growth of the high-throughput screening services market.
High-Throughput Screening Services Market Categorization By Product Type And Application
The high-throughput screening services market covered in this report is segmented –
1) By Products And Services: Instruments; Reagents And Kits; Services
2) By Technology: Ultra-high-throughput Screening; Cell-based Assays; Lab-on-a-chip; Label-free Technology
3) By Application: Target Identification; Primary Screening; Toxicology
4) By End User: Pharmaceutical And Biotechnology Firms; Academia And Research Institutes; Contract Research Organizations
Subsegments:
1) By Instruments: Automated Screening Systems; Liquid Handling Systems; Detection And Imaging Systems; Data Acquisition Systems
2) By Reagents And Kits: Assay Reagents; Screening Kits; Cell Based Reagents; Detection Reagents
3) By Services: Assay Development And Optimization Services; Primary Screening Services; Hit Confirmation And Validation; Data Analysis And Bioinformatics Support; Specialized Screens; Project Management And Reporting
#High-Throughput Screening Services Market Trends Influencing Long-Term Demand
Major companies in the high-throughput screening services market are concentrating on innovations in miniaturized and high-density assays, such as ultra-high screening speed with up to 27 detection channels, to enable faster, large-scale multiparametric analysis and accelerate drug discovery workflows. Ultra-high screening speed with up to 27 detection channels signifies the capability to rapidly analyze numerous biological parameters concurrently, thereby increasing data output and efficiency in high-throughput screening studies. For instance, in May 2024, Evotec SE, a Germany-based drug discovery and development services company, unveiled comprehensive high-throughput screening services as a component of its integrated early discovery platform. Evotec conducts extensive biochemical and cell-based HTS campaigns utilizing highly automated, miniaturized assay systems and advanced data analytics. The company assists pharmaceutical and biotechnology partners by promptly identifying hit compounds and optimizing lead selection, consequently speeding up early-stage drug discovery programs.
High-Throughput Screening Services Market Company Landscape And Strategic Competition
Major companies operating in the high-throughput screening services market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Corning Incorporated, Eurofins Scientific SE, Charles River Laboratories International Inc., Revvity Inc., Bio-Rad Laboratories Inc., Hamilton Company, Tecan Group Ltd., GenScript Biotech Corporation, Promega Corporation, Molecular Devices LLC, ShanghAI Medicilon Inc., Sygnature Discovery Limited, Selvita S.A., Cayman Chemical Company, Creative Bioarray Inc., Axxam S.p.A., Axcelead Inc., Creative Biolabs Inc., Enamine Ltd., Aurora Biomed Inc.
Access The Complete High-Throughput Screening Services Market Report:
High-Throughput Screening Services Market Geographic Distribution And Regional Opportunities
North America was the largest region in the high-throughput screening services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high-throughput screening services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
